Clinical Trials
Estudos Clínicos em Portugal
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Localização
Unidade Local de Saude de Braga, EPE /ID# 275394 (Braga, Portugal)
Gender
ALL
Idade
18 Years or more
Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1
Localização
Hospital Prof. Doutor Fernando Fonseca E.P.E. (Amadora, Portugal)
Gender
ALL
Idade
18 Years or more
Nuclear Magnetic Resonance for Embryo Ploidy Selection
Localização
Instituto Valenciano de Infertilidade (Lisbon, Portugal)
Gender
FEMALE
Idade
Between 18 Years and 48 Years
Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy
Localização
Centro Clinico Academico - Hospital de Braga (Braga, Portugal)
Gender
ALL
Idade
18 Years or more
Measuring Self-Efficacy on Portuguese Respiratory Patients on Pulmonary Rehabilitation
Localização
Instituto Nacional de Saúde Doutor Ricardo Jorge, Departamento de Epidemiologia (Lisbon, Portugal)
Gender
ALL
Idade
Between 26 Years and 89 Years
The Motor Neurological Soft Signs (MNSS) in Persons With Schizophrenia
Localização
Susana Guimarães (Lisbon, Portugal)
Gender
ALL
Idade
18 Years or more
Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse
Localização
Hospitais da Universidade de Coimbra (Coimbra, Portugal)
Gender
FEMALE
Idade
18 Years or more
Propofol Pharmacokinetics and Pharmacodynamics Modelling
Localização
Centro Hospitalar do Porto (Porto, Portugal)
Gender
ALL
Idade
18 Years or more
Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease
Localização
Hospital de Braga (Braga, Portugal)
Gender
ALL
Idade
18 Years or more
To Assess Efficacy and Safety of Batoclimab in Adult Participants With Active CIDP
Localização
Site Number - 3742 (Senhora da Hora, Portugal)
Gender
ALL
Idade
18 Years or more